{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:49:08Z","timestamp":1790340548329,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,5]],"date-time":"2011-08-05T00:00:00Z","timestamp":1312502400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00415-011-6194-7","type":"journal-article","created":{"date-parts":[[2011,8,3]],"date-time":"2011-08-03T22:31:37Z","timestamp":1312410697000},"page":"427-435","source":"Crossref","is-referenced-by-count":288,"title":["Anti-LRP4 autoantibodies in AChR- and MuSK-antibody-negative myasthenia gravis"],"prefix":"10.1007","volume":"259","author":[{"given":"Alexandra","family":"Pevzner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Schoser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoleta-Carmen","family":"Cosma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andromachi","family":"Karakatsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berthold","family":"Schalke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Melms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"6194_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0404.2006.00609.x","volume":"183","author":"F Romi","year":"2006","unstructured":"Romi F, Gilhus NE, Aarli JA (2006) Myasthenia gravis: disease severity and prognosis. Acta Neurol Scand Suppl 183:24\u201325","journal-title":"Acta Neurol Scand Suppl"},{"key":"6194_CR2","first-page":"5","volume":"26","author":"J Newsom-Davis","year":"2007","unstructured":"Newsom-Davis J (2007) The emerging diversity of neuromuscular junction disorders. Acta Myol 26:5\u201310","journal-title":"Acta Myol"},{"key":"6194_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1097\/WCO.0b013e32833cc968","volume":"23","author":"ME Farrugia","year":"2010","unstructured":"Farrugia ME, Vincent A (2010) Autoimmune mediated neuromuscular junction defects. Curr Opin Neurol 23:489\u2013495","journal-title":"Curr Opin Neurol"},{"key":"6194_CR4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1084\/jem.144.3.726","volume":"144","author":"JM Lindstrom","year":"1976","unstructured":"Lindstrom JM, Einarson BL, Lennon VA, Seybold ME (1976) Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. J Exp Med 144:726\u2013738","journal-title":"J Exp Med"},{"key":"6194_CR5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1749-6632.1987.tb51285.x","volume":"505","author":"DB Drachman","year":"1987","unstructured":"Drachman DB, de Silva S, Ramsay D, Pestronk A (1987) Humoral pathogenesis of myasthenia gravis. Ann N Y Acad Sci 505:90\u2013105","journal-title":"Ann N Y Acad Sci"},{"key":"6194_CR6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0079-6123(08)64654-3","volume":"49","author":"AG Engel","year":"1979","unstructured":"Engel AG (1979) The immunopathological basis of acetylcholine receptor deficiency in myasthenia gravis. Prog Brain Res 49:423\u2013434","journal-title":"Prog Brain Res"},{"key":"6194_CR7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mus.880130507","volume":"13","author":"J Burges","year":"1990","unstructured":"Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A (1990) A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro. Muscle Nerve 13:407\u2013413","journal-title":"Muscle Nerve"},{"key":"6194_CR8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"7","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 7:365\u2013368","journal-title":"Nat Med"},{"key":"6194_CR9","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1097\/01.LAB.0000028144.48023.9B","volume":"82","author":"F Scuderi","year":"2002","unstructured":"Scuderi F, Marino M, Colonna L, Mannella F, Evoli A, Provenzano C, Bartoccioni E (2002) Anti-p110 autoantibodies identify a subtype of \u201cseronegative\u201d myasthenia gravis with prominent oculobulbar involvement. Lab Invest 82:1139\u20131146","journal-title":"Lab Invest"},{"key":"6194_CR10","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","volume":"55","author":"J McConville","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A (2004) Detection and characterization of MuSK antibodies in seronegative myasthenia gravis. Ann Neurol 55:580\u2013584","journal-title":"Ann Neurol"},{"key":"6194_CR11","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/mus.22006","volume":"44","author":"JT Guptill","year":"2011","unstructured":"Guptill JT, Sanders DB, Evoli A (2011) Anti-musk antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts. Muscle Nerve 44:36\u201340","journal-title":"Muscle Nerve"},{"key":"6194_CR12","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0896-6273(95)90146-9","volume":"15","author":"DM Valenzuela","year":"1995","unstructured":"Valenzuela DM, Stitt TN, Distefano PS, Rojas E, Mattsson K, Compton DL, Nunez L, Park JS, Stark JL, Gies DR, Thomas S, Le Beau MM, Fernald AA, Copeland NG, Jenkins NA, Burden SJ, Glass DJ, Yancopoulos GD (1995) Receptor tyrosine kinase specific for the skeletal muscle lineage: expression in embryonic muscle, at the neuromuscular junction, and after injury. Neuron 15:573\u2013584","journal-title":"Neuron"},{"key":"6194_CR13","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1101\/SQB.1996.061.01.046","volume":"61","author":"DJ Glass","year":"1996","unstructured":"Glass DJ, DeChiara TM, Stitt TN, Distefano PS, Valenzuela DM, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation and is a functional receptor for agrin. Cold Spring Harb Symp Quant Biol 61:435\u2013444","journal-title":"Cold Spring Harb Symp Quant Biol"},{"key":"6194_CR14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0896-6273(00)80303-7","volume":"18","author":"ED Apel","year":"1997","unstructured":"Apel ED, Glass DJ, Moscoso LM, Yancopoulos GD, Sanes JR (1997) Rapsyn is required for MuSK signaling and recruits synaptic components to a MuSK-containing scaffold. Neuron 18:623\u2013635","journal-title":"Neuron"},{"key":"6194_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jneuroim.2008.05.032","volume":"201\u2013202","author":"DB Sanders","year":"2008","unstructured":"Sanders DB, Juel VC (2008) MuSK-antibody positive myasthenia gravis: questions from the clinic. J Neuroimmunol 201\u2013202:85\u201389","journal-title":"J Neuroimmunol"},{"key":"6194_CR16","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/s00415-010-5823-x","volume":"258","author":"G Cenacchi","year":"2011","unstructured":"Cenacchi G, Valentina P, Marina F, Elena P, Corrado A (2011) Comparison of muscle ultrastructure in myasthenia gravis with anti-MuSK and anti-AChR antibodies. J Neurol 258:746\u2013752","journal-title":"J Neurol"},{"key":"6194_CR17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jneuroim.2005.08.016","volume":"170","author":"O Benveniste","year":"2005","unstructured":"Benveniste O, Jacobson L, Farrugia ME, Clover L, Vincent A (2005) MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo. J Neuroimmunol 170:41\u201348","journal-title":"J Neuroimmunol"},{"key":"6194_CR18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jneuroim.2006.05.017","volume":"177","author":"N Boneva","year":"2006","unstructured":"Boneva N, Frenkian-Cuvelier M, Bidault J, Brenner T, Berrih-Aknin S (2006) Major pathogenic effects of anti-MuSK antibodies in myasthenia gravis. J Neuroimmunol 177:119\u2013131","journal-title":"J Neuroimmunol"},{"key":"6194_CR19","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jneuroim.2007.01.010","volume":"185","author":"ME Farrugia","year":"2007","unstructured":"Farrugia ME, Bonifati DM, Clover L, Cossins J, Beeson D, Vincent A (2007) Effect of sera from AChR-antibody negative myasthenia gravis patients on AChR and MuSK in cell cultures. J Neuroimmunol 185:136\u2013144","journal-title":"J Neuroimmunol"},{"key":"6194_CR20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","volume":"1132","author":"A Vincent","year":"2008","unstructured":"Vincent A, Leite MI, Farrugia ME, Jacob S, Viegas S, Shiraishi H, Benveniste O, Morgan BP, Hilton-Jones D, Newsom-Davis J, Beeson D, Willcox N (2008) Myasthenia gravis seronegative for acetylcholine receptor antibodies. Ann N Y Acad Sci 1132:84\u201392","journal-title":"Ann N Y Acad Sci"},{"key":"6194_CR21","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/brain\/awn092","volume":"131","author":"MI Leite","year":"2008","unstructured":"Leite MI, Jacob S, Viegas S, Cossins J, Clover L, Morgan BP, Beeson D, Willcox N, Vincent A (2008) IgG1 antibodies to acetylcholine receptors in \u2018seronegative\u2019 myasthenia gravis. Brain 131:1940\u20131952","journal-title":"Brain"},{"key":"6194_CR22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ana.20386","volume":"57","author":"MI Leite","year":"2005","unstructured":"Leite MI, Strobel P, Jones M, Micklem K, Moritz R, Gold R, Niks EH, Berrih-Aknin S, Scaravilli F, Canelhas A, Marx A, Newsom-Davis J, Willcox N, Vincent A (2005) Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann Neurol 57:444\u2013448","journal-title":"Ann Neurol"},{"key":"6194_CR23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2005.01137.x","volume":"12","author":"F Romi","year":"2005","unstructured":"Romi F, Aarli JA, Gilhus NE (2005) Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 12:413\u2013418","journal-title":"Eur J Neurol"},{"key":"6194_CR24","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(86)92259-2","volume":"1","author":"S Mossman","year":"1986","unstructured":"Mossman S, Vincent A, Newsom-Davis J (1986) Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity. Lancet 1:116\u2013119","journal-title":"Lancet"},{"key":"6194_CR25","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2008.10.006","volume":"60","author":"B Zhang","year":"2008","unstructured":"Zhang B, Luo S, Wang Q, Suzuki T, Xiong WC, Mei L (2008) LRP4 serves as a coreceptor of agrin. Neuron 60:285\u2013297","journal-title":"Neuron"},{"key":"6194_CR26","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2008.10.002","volume":"135","author":"N Kim","year":"2008","unstructured":"Kim N, Stiegler AL, Cameron TO, Hallock PT, Gomez AM, Huang JH, Hubbard SR, Dustin ML, Burden SJ (2008) Lrp4 is a receptor for agrin and forms a complex with MuSK. Cell 135:334\u2013342","journal-title":"Cell"},{"key":"6194_CR27","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ana.22312","volume":"69","author":"O Higuchi","year":"2011","unstructured":"Higuchi O, Hamuro J, Motomura M, Yamanashi Y (2011) Autoantibodies to low-density lipoprotein receptor-related protein\u00a04 in myasthenia gravis. Ann Neurol 69:418\u2013422","journal-title":"Ann Neurol"},{"key":"6194_CR28","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ydbio.2007.04.020","volume":"307","author":"JE Schr\u00f6der","year":"2007","unstructured":"Schr\u00f6der JE, Tegeler MR, Grosshans U, Porten E, Blank M, Lee J, Esapa C, Blake DJ, Kr\u00f6ger S (2007) Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS. Dev Biol 307:62\u201378","journal-title":"Dev Biol"},{"key":"6194_CR29","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1074\/jbc.270.7.3392","volume":"270","author":"G Tsen","year":"1995","unstructured":"Tsen G, Halfter W, Kr\u00f6ger S, Cole GJ (1995) Agrin is a heparan sulfate proteoglycan. J Biol Chem 270:3392\u20133399","journal-title":"J Biol Chem"},{"key":"6194_CR30","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0960-8966(03)00036-1","volume":"13","author":"A Eusebio","year":"2003","unstructured":"Eusebio A, Oliveri F, Barzaghi P, Ruegg MA (2003) Expression of mouse agrin in normal, denervated and dystrophic muscle. Neuromuscul Disord 13:408\u2013415","journal-title":"Neuromuscul Disord"},{"key":"6194_CR31","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1523\/JNEUROSCI.10-11-03576.1990","volume":"10","author":"BG Wallace","year":"1990","unstructured":"Wallace BG (1990) Inhibition of agrin-induced acetylcholine-receptor aggregation by heparin, heparan sulfate, and other polyanions. J Neurosci 10:3576\u20133582","journal-title":"J Neurosci"},{"key":"6194_CR32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1083\/jcb.128.4.625","volume":"128","author":"M Gesemann","year":"1995","unstructured":"Gesemann M, Denzer AJ, Ruegg MA (1995) Acetylcholine receptor aggregating activity of agrin isoforms and mapping of the active site. J Cell Biol 128:625\u2013636","journal-title":"J Cell Biol"},{"key":"6194_CR33","doi-asserted-by":"crossref","first-page":"6467","DOI":"10.1074\/jbc.273.11.6467","volume":"273","author":"C Hopf","year":"1998","unstructured":"Hopf C, Hoch W (1998) Dimerization of the muscle-specific kinase induces tyrosine phosphorylation of acetylcholine receptors and their aggregation on the surface of myotubes. J Biol Chem 273:6467\u20136473","journal-title":"J Biol Chem"},{"key":"6194_CR34","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.37.8.1329","volume":"37","author":"T Yamamoto","year":"1987","unstructured":"Yamamoto T, Sato T, Sugita H (1987) Antifilamin, antivinculin, and antitropomyosin antibodies in myasthenia gravis. Neurology 37:1329\u20131333","journal-title":"Neurology"},{"key":"6194_CR35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0165-5728(93)90085-D","volume":"43","author":"CZ Lu","year":"1993","unstructured":"Lu CZ, Lu L, Hao ZS, Xia DG, Qain J, Arnason BG (1993) Antibody-secreting cells to acetylcholine receptor and to presynaptic membrane receptor in seronegative myasthenia gravis. J Neuroimmunol 43:145\u2013149","journal-title":"J Neuroimmunol"},{"key":"6194_CR36","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ygeno.2006.01.007","volume":"87","author":"D Simon-Chazottes","year":"2006","unstructured":"Simon-Chazottes D, Tutois S, Kuehn M, Evans M, Bourgade F, Cook S, Davisson MT, Guenet JL (2006) Mutations in the gene encoding the low-density lipoprotein receptor LRP4 cause abnormal limb development in the mouse. Genomics 87:673\u2013677","journal-title":"Genomics"},{"key":"6194_CR37","doi-asserted-by":"crossref","first-page":"e7930","DOI":"10.1371\/journal.pone.0007930","volume":"4","author":"HY Choi","year":"2009","unstructured":"Choi HY, Dieckmann M, Herz J, Niemeier A (2009) Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo. PLoS One 4:e7930","journal-title":"PLoS One"},{"key":"6194_CR38","doi-asserted-by":"crossref","first-page":"e10418","DOI":"10.1371\/journal.pone.0010418","volume":"5","author":"CM Karner","year":"2010","unstructured":"Karner CM, Dietrich MF, Johnson EB, Kappesser N, Tennert C, Percin F, Wollnik B, Carroll TJ, Herz J (2010) Lrp4 regulates initiation of ureteric budding and is crucial for kidney formation\u2013a mouse model for Cenani-Lenz syndrome. PLoS One 5:e10418","journal-title":"PLoS One"},{"key":"6194_CR39","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1093\/hmg\/ddi381","volume":"14","author":"EB Johnson","year":"2005","unstructured":"Johnson EB, Hammer RE, Herz J (2005) Abnormal development of the apical ectodermal ridge and polysyndactyly in Megf7-deficient mice. Hum Mol Genet 14:3523\u20133538","journal-title":"Hum Mol Genet"},{"key":"6194_CR40","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1242\/dev.02696","volume":"133","author":"SD Weatherbee","year":"2006","unstructured":"Weatherbee SD, Anderson KV, Niswander LA (2006) LDL-receptor-related protein\u00a04 is crucial for formation of the neuromuscular junction. Development 133:4993\u20135000","journal-title":"Development"},{"key":"6194_CR41","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1242\/dev.038711","volume":"137","author":"H Wu","year":"2010","unstructured":"Wu H, Xiong WC, Mei L (2010) To build a synapse: signaling pathways in neuromuscular junction assembly. Development 137:1017\u20131033","journal-title":"Development"},{"key":"6194_CR42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","volume":"85","author":"TM DeChiara","year":"1996","unstructured":"DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, Distefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501\u2013512","journal-title":"Cell"},{"key":"6194_CR43","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ajhg.2010.03.004","volume":"86","author":"Y Li","year":"2010","unstructured":"Li Y, Pawlik B, Elcioglu N, Aglan M, Kayserili H, Yigit G, Percin F, Goodman F, Nurnberg G, Cenani A, Urquhart J, Chung BD, Ismail S, Amr K, Aslanger AD, Becker C, Netzer C, Scambler P, Eyaid W, Hamamy H, Clayton-Smith J, Hennekam R, Nurnberg P, Herz J, Temtamy SA, Wollnik B (2010) LRP4 mutations alter Wnt\/beta-catenin signaling and cause limb and kidney malformations in Cenani-Lenz syndrome. Am J Hum Genet 86:696\u2013706","journal-title":"Am J Hum Genet"},{"key":"6194_CR44","first-page":"2555","volume":"123","author":"WW Wang","year":"2010","unstructured":"Wang WW, Hao HJ, Gao F (2010) Detection of multiple antibodies in myasthenia gravis and its clinical significance. Chin Med J (Engl) 123:2555\u20132558","journal-title":"Chin Med J (Engl)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6194-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-011-6194-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-011-6194-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T15:04:32Z","timestamp":1560438272000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-011-6194-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,5]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["6194"],"URL":"https:\/\/doi.org\/10.1007\/s00415-011-6194-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.720966356.793519635","asserted-by":"object"}]},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,5]]}}}